{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:40:51Z","timestamp":1713159651047},"reference-count":29,"publisher":"American Public Health Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[2001,1,1]]},"abstract":"<jats:p>OBJECTIVES: This study evaluated a novel approach to the delivery of directly observed therapy (DOT) for tuberculosis in Haiti. METHODS: A total of 194 patients (152 HIV seropositive, 42 HIV seronegative) received daily unsupervised triple-drug therapy for 4 to 8 weeks, followed by twice-weekly 2-drug therapy for the remainder of the 6-month period. DOT was deferred until initiation of the twice-weekly phase. RESULTS: A total of 169 of 194 patients (87.1%) completed the 6-month course. The program of deferred DOT had an effectiveness of 85%. Overall cost was reduced by approximately 40%. CONCLUSIONS: Flexible approaches to DOT, integrating behavioral knowledge, cost considerations, and practicality may improve completion rates and program effectiveness.<\/jats:p>","DOI":"10.2105\/ajph.91.1.138","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T08:56:28Z","timestamp":1322816188000},"page":"138-141","source":"Crossref","is-referenced-by-count":6,"title":["A novel approach to directly observed therapy for tuberculosis in an HIV-endemic area"],"prefix":"10.2105","volume":"91","member":"844","reference":[{"key":"p_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.6.1623"},{"key":"p_2","unstructured":"Advisory Council for the Elimination of Tuberculosis. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993;42(RR-7)."},{"key":"p_3","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30194-8"},{"key":"p_4","doi-asserted-by":"publisher","DOI":"10.1126\/science.257.5073.1055"},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/147.5.1311"},{"key":"p_6","first-page":"97","volume":"32","author":"Demissie M","year":"1994","journal-title":"Ethiop Med J."},{"key":"p_7","first-page":"458","volume":"112","author":"Luscher T","year":"1982","journal-title":"Schweiz Med Wochenschr."},{"key":"p_8","unstructured":"Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance In Health Care. Baltimore, Md: Johns Hopkins University Press; 1979:49-62."},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1080\/09540129108253073"},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.3.725"},{"key":"p_11","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91817-6"},{"key":"p_12","unstructured":"World Health Organization (WHO). Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, Switzerland: WHO; 1993."},{"key":"p_13","unstructured":"Enarson DA, International Union Against Tuberculosis and Lung Disease. Tuberculosis Guide for Low Income Countries. Frankfurt am Main, Germany: Verlagsgruppe GmbH; 1994."},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(05)80015-2"},{"key":"p_15","unstructured":"WHOReport on the Tuberculosis Epidemic. Geneva, Switzerland: World Health Organization; 1995."},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.149.5.8173779"},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92640-9"},{"key":"p_18","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.4.8887603"},{"key":"p_19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330406"},{"key":"p_20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7101.187a"},{"key":"p_21","doi-asserted-by":"crossref","unstructured":"World Bank. World Development Report 1993: Investing in Health. Oxford, England: Oxford University Press; 1993.","DOI":"10.1596\/978-0-1952-0890-0"},{"key":"p_22","unstructured":"Central Intelligence Agency. The world factbook 2000-Haiti. Available at: http:\/\/www.cia.gov\/ cia\/publications\/factbook\/geos\/ha.html. Accessed October 8, 2000."},{"key":"p_23","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.Supplement_2.S442"},{"key":"p_24","first-page":"203","volume":"4","author":"Cole S","year":"1993","journal-title":"Ann Inst Pasteur."},{"key":"p_25","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.1.2"},{"key":"p_26","unstructured":"World Health Organization (WHO). Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, Switzerland: WHO; 1997."},{"key":"p_27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04022-7"},{"key":"p_28","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.88.7.1052"},{"key":"p_29","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.4.605"}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.91.1.138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T05:23:40Z","timestamp":1713158620000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.91.1.138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1,1]]}},"alternative-id":["10.2105\/AJPH.91.1.138"],"URL":"https:\/\/doi.org\/10.2105\/ajph.91.1.138","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}